• Regorafenib (BAY 73-4506) Workflows in Tumor and Angiogenesi

  2026-06-20

  Regorafenib (BAY 73-4506) stands out as a multikinase inhibitor enabling precise, stepwise interrogation of angiogenesis and tumor progression in advanced cancer models. This guide translates recent breakthroughs—especially novel RRM2 targeting mechanisms—into actionable protocols and troubleshooting strategies for both in vitro and in vivo research.

• Phenothiazines Enhance Macrophage Antibacterial Activity via

  2026-06-19

  This study demonstrates that phenothiazines, including promethazine hydrochloride, enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) production and autophagy. These findings provide mechanistic insight into host-directed therapeutic approaches for combating intracellular bacterial infections and overcoming antibiotic resistance.

• In Vitro Activity of Temafloxacin Against Gram-Negative Path

  2026-06-19

  This article reviews the reference study's comprehensive in vitro analysis of temafloxacin against clinically significant Gram-negative bacteria, highlighting its comparative potency and spectrum versus other fluoroquinolones. Findings inform both antibacterial research and the contextual positioning of third-generation cephalosporins for modeling infectious diseases.

• Faropenem Sodium: Penem Antibiotic for Broad-Spectrum Bacter

  2026-06-18

  Faropenem sodium is a non-classical β-lactam antibiotic with high oral bioavailability and exceptional stability against β-lactamases. Its broad-spectrum activity includes both Gram-positive and Gram-negative pathogens, with demonstrated efficacy against resistant and anaerobic bacteria. This article details Faropenem sodium’s mechanism, applications, and validated laboratory benchmarks.

• Tranexamic Acid in Translational Hemostasis: Mechanisms & Fu

  2026-06-18

  This thought-leadership article explores Tranexamic Acid's mechanistic insights and strategic relevance for translational researchers, highlighting its role as an antifibrinolytic agent, recent biomaterial innovations, and guidance for experimental workflows. It extends beyond conventional product overviews by analyzing the competitive landscape, clinical implications, and the emergent synergy of Tranexamic Acid in next-generation wound care, culminating in actionable recommendations and a future-facing outlook.

• 2,7-Dichlorodihydrofluorescein Diacetate for ROS Assays: Adv

  2026-06-17

  2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) is a gold standard fluorogenic probe for quantifying intracellular ROS, with flexible compatibility across fluorescence microscopy, flow cytometry, and high-throughput plate assays. This article offers advanced protocol strategies, troubleshooting insights, and a translational perspective on optimizing DCFH-DA workflows in disease-relevant models, including recent innovations in inflammatory research.

• Pharmacokinetic-Pharmacodynamic Insights: Cefazedone in CAP

  2026-06-17

  This article analyzes a clinical pharmacokinetic and pharmacodynamic (PK/PD) study evaluating intravenous cefazedone sodium for the treatment of mild to moderate community-acquired pneumonia (CAP). The research demonstrates that a 2 g every 12 hours regimen achieves effective fT>MIC and clinical cure rates, supporting rational dosing strategies for infections caused by susceptible bacteria.

• Flubendazole in Tumor Microenvironment Research: Bridging Au

  2026-06-16

  Explore how Flubendazole, a high-purity autophagy modulator, uniquely empowers research into the tumor microenvironment and macrophage-driven cancer progression. This in-depth analysis integrates mechanistic insights and protocol guidance for advanced autophagy modulation research.

• Tobramycin in Microbiology Research: Protocols and Optimizat

  2026-06-16

  Tobramycin’s high purity and water solubility make it a gold-standard aminoglycoside antibiotic for studying Gram-negative pathogens, protein synthesis inhibition, and antibiotic resistance. This article delivers actionable workflows, comparative data, and troubleshooting strategies that empower researchers to maximize reliability and reproducibility using APExBIO’s Tobramycin.

• BOP Reagent in Advanced Peptide Synthesis: Protocols & Solut

  2026-06-15

  BOP reagent enables high-efficiency peptide and phenyl ester synthesis through robust carboxyl group activation, making it a cornerstone for advanced prodrug and peptide workflows. Learn how to optimize experimental setups, troubleshoot common issues, and apply insights from cutting-edge oncology research.

• L1023 Anti-Cancer Compound Library: Advanced Oncology Workfl

  2026-06-15

  The L1023 Anti-Cancer Compound Library empowers high-throughput screening and target discovery, offering oncology teams validated, cell-permeable inhibitors against key cancer pathways. This guide details optimized workflows, troubleshooting strategies, and the translational potential unlocked by the DiscoveryProbe™ platform in modern cancer research.

• PSPro: Single-Cell-Type Spatial Proteomics via Proximity Lab

  2026-06-14

  This study introduces PSPro, an antibody-guided proximity proteomics strategy enabling all-at-once spatial proteome profiling with single-cell-type resolution in complex tissues. By optimizing labeling parameters and integrating laser microdissection, PSPro reveals spatial heterogeneity among cell subsets, advancing the field beyond conventional mass spectrometry or antibody imaging approaches.

• Ionomycin Calcium Salt: Precision Calcium Ionophore in Cance

  2026-06-13

  Ionomycin calcium salt enables researchers to modulate intracellular Ca2+ with exceptional control, facilitating advanced studies in cancer cell signaling, ribosome biogenesis, and apoptosis pathways. This article delivers actionable workflows, real-world troubleshooting, and insights from recent translational oncology breakthroughs, highlighting why APExBIO’s formulation is trusted for reproducible results.

• Spleen-Targeted Neoantigen mRNA Vaccines Drive TLS in HCC

  2026-06-12

  Lin et al. introduce a spleen-targeted neoantigen mRNA vaccine (STNvac) that elicits ISG15+ CD8+ T cell responses and tertiary lymphoid structure (TLS) formation in hepatocellular carcinoma. This study clarifies how organ-selective mRNA delivery enhances antitumor immunity and provides mechanistic insights relevant for designing next-generation mRNA immunotherapies.

• Comparative Antibacterial Activity of Cefazedone and β-Lacta

  2026-06-12

  This article reviews a foundational study comparing the antibacterial activities of N-formimidoyl thienamycin (MK0787) with several recently developed β-lactam antibiotics, including cefazedone. The findings highlight cefazedone's efficacy against both Gram-positive and Gram-negative pathogens, informing antibiotic selection and experimental design for resistant clinical isolates.

452 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page